InsiderTrades

Reider Paul

SEC CIK 1970033 · EDGAR

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
CHRSCoherus Oncology, Inc.Chief Commercial Off 82.1K — — 72023-04-012025-01-20

Most active insiders at CHRS, 12 months

#InsiderTitleBoughtSold
1 Ryan Michael LeeDir ——
2 McMichael Bryan JCFO ——
3 O'Donnell-Tormey JillDir ——
4 Newton Charles W.Dir ——
5 Newcomer Lee NisleyDir ——
6 Satvat Ali J.Dir ——
7 Karachun Rita ADir ——
8 Wahlstrom MatsDir ——
9 Lanfear Dennis MPres, CEO, Dir ——

Reider Paul made no open-market trades at CHRS in the last 12 months.

Transactions 7

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
2025-01-22 2025-01-20 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $1.39 -4,858 82.1K -6% -$6,753
D 2025-01-07 2025-01-04 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $1.66 -2,277 86.9K -3% -$3,780
2024-12-17 2024-12-13 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $1.61 -2,073 89.2K -2% -$3,338
2024-01-23 2024-01-20 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $2.44 -4,854 81.3K -6% -$11.8K
2024-01-08 2024-01-04 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $2.92 -2,275 86.1K -3% -$6,643
2023-12-15 2023-12-13 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $2.37 -2,049 88.4K -2% -$4,856
2023-04-04 2023-04-01 CHRS Coherus Oncology, Inc. Reider Paul Chief Commercial Off F - Tax $6.84 -2,451 87.1K -3% -$16.8K

Purchase Sale Sale after option exercise All abbreviations